Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Conditions
Covid-19 Pandemics · Tuberculosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shoklo Malaria Research Unit (SMRU), Mae Ramat, Changwat Tak, Thailand
Study leads
François Nosten, Professor
Principal Investigator
Shoklo Malaria Research Unit